Related Experiment Video

Updated: Jul 14, 2026

In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
10:27

In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears

Published on: February 21, 2018

ULTRASONICS in Meniere's disease

    Lancet (London, England)
    |January 9, 1960
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    MENIERE'S DISEASES/therapyULTRASONICS/therapy

    More Related Videos

    Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
    04:11

    Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease

    Published on: April 28, 2023

    Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
    02:34

    Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

    Published on: May 10, 2024

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
    10:27

    In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears

    Published on: February 21, 2018

    Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
    04:11

    Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease

    Published on: April 28, 2023

    Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
    02:34

    Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

    Published on: May 10, 2024

    Related Concept Videos

    Mitral Regurgitation III: Medical Management01:25

    Mitral Regurgitation III: Medical Management

    Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

    Articles linked to this work by shared authors, journal, and citation graph.

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

    Lancet (London, England)·2026

    [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

    Lancet (London, England)·2026

    Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

    Lancet (London, England)·2026

    Transforming the treatment of autoimmune skin diseases: a journey through biologic therapies.

    Expert opinion on biological therapy·2026

    Specificity of the Interactions of Folate-Based Vectors with Folate Receptor-α.

    The journal of physical chemistry. B·2026

    Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study.

    The Journal of dermatological treatment·2026

    Nanobodies targeting SARS-CoV-2 variants.

    Acta pharmaceutica Sinica. B·2026

    In vivo CRISPR editing for cancer immunotherapy.

    Frontiers in immunology·2026

    Subcutaneous administration of antibody-drug conjugates: current challenges, emerging opportunities, and future perspectives.

    Antibody therapeutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us